Gastrointestinal protective barrier



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Current views on the protective function of the gastrointestinal barrier are based on the capacity of its surface and glandular epi-theliocytes to synthesize the mucins. The most significant types of gel-forming mucins are MUC 5AC, MUC 5B, MUC 6 and MUC 2. The type of the mucin is cell-specific and is determined by the character of cell phenotype. The change of the mucin type may be the major factor in the development of pathology. The protective mucin function is realized with the participation of trefoil peptides. The problem of the mechanism of mucin-trefoil peptide macromolecular complex formation in normal and patho-logical states is discussed.

About the authors

G M MOGYLNAYA

Kuban State Medical University

Кафедра гистологии; Кубанский государственный медицинский университет; Kuban State Medical University

V L MOGILNAYA

Russian Center of Functional Surgical Gastroenterology

Russian Center of Functional Surgical Gastroenterology

References

  1. Аруин Л.И., Капулпер Л.Л. и Исаков В.А. Морфологическая диагностика болезней желудка и кишечника. М., Триада-Х, 1993.
  2. Могильная В.Л. К вопросу о влиянии ваготомии на эпителиоциты зоны регенерации СОЖ. Юж.-Рос. мед. журн., 2004, №3, с. 74-75.
  3. Могильная В.Л. Сравнительная характеристика слизистой оболочки желудка после корригирующих операций. Изв. вузов Сев.-Кавк. региона, Естеств. науки, 2006, с. 126-127.
  4. Могильная Г.М., Шубич М.Г., Дудецкий В.И. и Богатырь Л.Я. Гистохимическая характеристика секрета покровных эпителноцитов желудка в сравнительном аспекте. Арх. анат., 1978, т. 75, вып. 9, с. 43-51.
  5. Могильная Г.М. и Шубич М.Г. Проблема ульцерогенезз в свете эволюционно обусловленной нестойкости защитного барьера желудка. Успехи соврем, биол., 1984, т. 98, №5, с. 235-245.
  6. Успенский В.М. Функциональная морфология желудка. Л., Наука. 19S6.
  7. Циммерман Я.С., Михайловская Л.В., Фрейнд Г.Г. и Зиннатулин М.Р. Повышение защитных потенций слизистой оболочки желудка и двенадцатиперстной кишки - перспективный путь лечения язвенной болезни. Пермск. мед. журн., 1994, №1-4, с. 34-42.
  8. Шубич М.Г. и Могильная Г.М. Гистохимия желудка позвоночных в таксономическом и эволюционном аспекте. Журн. общей биол., 1981, т. 52, № 2, с. 276-238.
  9. Ahnen D., Poulsom R., Stamp G. et al. The ulceration-associated cell lineage (UACl) reiterates the Brunner's gland differentiation but acquires the proliferative organization of the gastric glands. J. Pathol., 1994, v. 173, p. 317-326.
  10. Alison M., Chiney R., Poulsom R. et al. Experimental ulceration trefoil factor and transforming growth factor alpha mRNAs in rat stomach. J. Pathol., 1995, v. 175, p. 405-414.
  11. Allen A. Gastrointestinal mucus. Jn: Hanbook of Physiology. Gastrointestinal Physiology. Salivary, Gastric, Pancreatic, and Hepatobiliary Secretion. Bethesda, MD: Am. Physiol. Soc. 1939. sect. 6, v. 3, chapt. 19, p. 359-332.
  12. Allen A. and Flemstrom G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am. J. Physiol. Cell Physiol., 2005, v. 288, p. 1-43.
  13. Allen A. and Garner A. Gastric mucus and bicarbonate secretion and their possible role in mucosal protection. Gut, 1980, v. 21, p. 249-262.
  14. Allen A. and Pearson J. Mucus glycoproteins of the normal gastrointestinal tract. Eur. J. Gastroenterol. Hepatol., 1993, v. 5, p. 193-199.
  15. Atuma С Gastrointestinal mucosal protective mechanisms. Acta Univer. Upsal., 2000.
  16. Bartman A., Busine M.-P., Aubert J.-P. et al. The MUC 6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J. Pathol., 1998, v. 186, p. 393-405.
  17. Buisine M-P., Desreumaux P., Leteurtre E. et al. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut, 2001, v. 49, p. 544-551.
  18. Chinery R. and Playford R. Combined intestinal trefoil factor and epidermal growth factor are prophylactic against indomethacin-induced gastric damage in the rat. Clin. Sci. (Colch), 1995, v. 83, p. 401-403.
  19. Chu S., Tanaka S., Kaunitz J. et al. Dynamic regulation of gastric surface pH by luminal pH. J. Clin. Invest, 1999, v. 103, p. 605-612.
  20. Davenport V/. Why the stomach does not digest itself? Sci. Am., 1972, v.1, p. 87-93.
  21. Engel E., Guth P., Nishizaki I. et al. Barrier function of the gastric mucins gel. Am. J. Physiol., 1995, v. 269, p. 994-999.
  22. Farrell J., Taupin D., Koh T. et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J. Clin. Invest., 2002, v. 109. p. 193-204.
  23. Figura N. Helicobacter pylori factors involved in the development of gastroduodenal mucosal damage and ulceration. J. Clin. Gastroenterol., 1997, v. 25, suppl.1, p. 149-163.
  24. Filipe M.J. Mucins in the human gastrointestinal epithelium. A. review. Invest. Cell Pathol., 1979,2, p. 195-216.
  25. Filipe M. and Ramachandra S. The histochemistry of intestinal mucins; changes in disease. In: Gastrointestinal and oesophageal pathology. Edinburgh: Churchill Livingstone, 1995, p. 73-95.
  26. Fiocca R, Villani L, Tenti P. et al. Characterisation of four main cell types in gastric cancer: foveoiar, mucopeptic intestinal columnar and goblet cells. A histopathologic, histochemical and ultrastuctural study of "early" and "advanced" tumours. Pathol. Res. Pract., 1987. v. 182, p. 303-325.
  27. Gum J. Human mucin glycoproteins: varied structures predict diverse properties and specific functions. Biochem. Soc. Trans., 1995, v. 23, p. 795-799. .
  28. Нanbу A., Poulsom R., Elia G. et al. The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in «gastric metaplasia» of the proximal duodenum implications for the nature of «gastric metaplasia-. J. Pathol., 1993, v. 169, p. 355-360.
  29. Ho S., Anway R. and Khaiil Z. Spatial organization of MUC 5 AC and MUC 6 mucins within the surface mucous layer of the stomach. DDW Meeting of the Amer. Gastroenterol. Assoc, San Diego, USA. 2000, abstr. 1396.
  30. Johanson M., Synnerstad J. and Holm L. Acid transport through channels in the mucin ager of rat stomach. Gastroenterology, 2000, v. 119, p. 1297-1304.
  31. Jorgensen K., Thim L and Jacobsen H. Pancreatic spasmolytic polypeptide (PSP): 1. reparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul. Pept., 1982, v. 250, p. 85-90.
  32. Katoh M. Trefoil factors and human gastric cancer. Int. J. Mol. Med., 2003, v. 12, p. 3-9.
  33. Khulusi S., Hanby A., Marrero J. et al. Expression of trefoil peptides pS2 and human spasmolytric polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut, 1995, v. 37, p. 205-209.
  34. Kindon H., Pothoulakis C, Thim L et al. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology, 1995, v. 109, p. 516-523.
  35. Kouznetsova I., Peitz U., Vieth M. et al. A gradient of TFF3 (trefoil factor family 3) peptide synthesis within the normal human gastric mucosa. Cell Tissue Res., 2004, v. 316, p. 155-165.
  36. Longman R., Douthwaite J., Sylvester R. et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut, 2000, v. 47, p. 792-800.
  37. Mashimo U., Wu D., Podolsky D. et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science, 1996, v. 274, p. 262-265.
  38. May F., SempI J., Newton J. et al. The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach. Gut, 2000, v. 46, p. 454-459.
  39. Modlin J.V. From prout to proton pump. Konstanz, Sohneizior-VerlagGmbh, 1995.
  40. Nentra M. and Forstner J. Gastrointestinal mucus: synthesis, secretion, function. In: Physiology of the gastrointestinal tract. New York, Raven Press, 1997, p. 975-1009.
  41. Otto W., Rao J., Cop U. et al. Effects of spasmolytic polypeptide on epithelial cell function. Eur. J. Biochem., 1996, v. 35, p. 64-72.
  42. Playford R., Marchbank Т., Chinery R. et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology, 1995, v. 108, p. 106-116.
  43. Podolsky D. Mechanisms of regulatory peptide action in the gastrointestinal tract: trefoil peptides. J. Gastroenterol. 2000, v.35,suppl.12,p.69-74.
  44. Podolsky D., Lynch-Devaneyk K., Stow J. et al. Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide targeted for apical secretion. J. Biol. Chem., 1993, v. 268, p. 6694-6702.
  45. Poulsom R. Trefoil peptides. Bailliers Clin., Gastroenterol., 1996, v. 10, p. 113-134.
  46. Reis C, David L., Nielsen P. et al. Immunohistochemical study of MUC 5 AC expression in human gastric carcinomas using a novel monoclonal antibody. Int. J. Cancer, 1997, v. 74, p. 112-121.
  47. Rhodes J. Mucins and inflammatory bowel disease. J. Med., 1997, v. 90, p. 79-82.
  48. Rio M., Chenard M., Wolf С et al. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology, 1991, v. 100, p. 375-379.
  49. Roberton A. and Corfield A. Mucin degradation and its significance in inflammatory conditions of the gastrointestinal tract. In: Medical importance of the normal microflora. Dordrecht, Kluwer Acad. Publ., 1993, p. 222-261.
  50. Roberts I. and Stoddart R. Ulcer-associated cell lineage («Pyloric metaplasia") in Crohn's disease: a lectin histochemical study. J. Pathol., 1993, v. 171, p. 13-19.
  51. Sands B. and Podolsky D. The trefoil peptide family. Ann. Rev. Physiol., 1996, v. 110, p. 489-497.
  52. Schmid R. and Ader G. NF-KB/Ree/LKB: Implications in gas-trointestinal diseases. Gastrointerology, 2000, v. 118, p. 1203-1228.
  53. Shubich M.G. and Mogilnaya G.M. Comparative histochemistry of carbohydrate containing biopolymers in the stomach of vertebrates. Zool. Jb. Anat., 1987, Bd. 116, S. 387-398.
  54. Strous G. and Dekker J. Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol., 1992, v. 27, p. 57-92.
  55. Tanaka S., Podolsky D., Engel E. et al. Human spasmolityc polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am. J. Physiol., 1997, v. 35, p. 1473-1480
  56. Thim L, Madsen F. and Poulsen S. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur. J. Clin. Invest., 2002, v. 32, p. 519-527.
  57. Tomasetto C, Masson R., Linaires J-L. et al. pS2/ TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology, 2000, v. 118, p. 70-80.
  58. Tran C, Cook G., Jeomans N. et al. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut, 1999, v. 44, p. 636-642.
  59. Van den Brink G., Tytgat K., Van der Hulst R.et al. H. pylori colocalises with MUC 5 AC in the human stomach. Gut, 2000, v. 46, p. 601-607.
  60. Van Kiinken В., Dekker J., Bullee H. and Finerhand A. Mucin gene structure and expression: protection vs adhesion. Am. J. Physiol., 1995, v. 269, p. 613-627.
  61. Walker M., Smolka A., Waller J. et al. Identification of parietal cells in gastric body mucosa with HMFG-2 monoclonal antibody. J. Clin. Pathol., 1995, v. 48, p. 832-834.
  62. Wallace J. and Granger D. The cellular and molecular basis of gastric mucosal defense. FASEB J., 1996, v. 10, p. 731-740.
  63. Weiss A., Babyatsky M., Otaga S. et al. Expressions of MUC2 and MUC3 in human normal, malignant and inflammatory intestinal tissues. J. Histochem. Cytochem., 1996, v. 44, p. 1161-1166.
  64. Williams S., McGuckin M., Gotley D. et al. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res., 1999, v. 59, p. 4083-4089.
  65. Wong W, Poulsom R. and Wright N. Trefoil peptides. Gut, 1999, v. 44, p. 890-895.
  66. Wright N.. Pike С and Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cell. Nature, 1990, v. 343, p. 82-85.
  67. Wright N.. Poulsom R., Stamp G. et al. Epidermal growth factor (EgF/VRO) induces expression regulatory peptides in damaged human gastrointestinal tissues. J. Pathol., 1990, v. 162, p. 279-284.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2007 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 0110212 от 08.02.1993.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies